- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech Undiscovered Gems With Strong Fundamentals
U.S. Pharmaceuticals & Biotech Undiscovered Gems With Strong Fundamentals
Results
3
High-performing small cap companies that haven't yet garnered significant analyst attention, and could lead to superior returns.
3 companies
Puma Biotechnology
Market Cap: US$272.5m
A biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally.
PBYI
US$5.47
7D
6.8%
1Y
89.9%
SIGA Technologies
Market Cap: US$597.9m
A commercial-stage pharmaceutical company, focuses on the health security market in the United States.
SIGA
US$8.30
7D
1.0%
1Y
19.9%
Gyre Therapeutics
Market Cap: US$793.8m
A pharmaceutical company, engages in the development and commercialization of small-molecule, anti-inflammatory, and anti-fibrotic drugs targeting organ fibrosis.
GYRE
US$8.30
7D
4.3%
1Y
-41.0%